scispace - formally typeset
S

Srinivasan Venkatramanan

Researcher at University of Virginia

Publications -  77
Citations -  2285

Srinivasan Venkatramanan is an academic researcher from University of Virginia. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 12, co-authored 63 publications receiving 1523 citations. Previous affiliations of Srinivasan Venkatramanan include The Chinese University of Hong Kong & Indian Institute of Science.

Papers
More filters
Journal ArticleDOI

Commentary on Ferguson, et al., "Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand".

TL;DR: A coarse taxonomy of models is discussed and the context and significance of the Imperial College and other models in contributing to the analysis of COVID-19 are explored.
Journal ArticleDOI

Using data-driven agent-based models for forecasting emerging infectious diseases.

TL;DR: This paper describes one such agent-based model framework developed for forecasting the 2014-2015 Ebola epidemic in Liberia, and subsequently used during the Ebola forecasting challenge, and concludes by highlighting how such a data-driven approach can be refined and adapted for future epidemics.
Journal ArticleDOI

Mathematical Models for COVID-19 Pandemic: A Comparative Analysis.

TL;DR: This article reviews some of the important mathematical models used to support the ongoing planning and response efforts in the COVID-19 pandemic and discusses their use, their mathematical form and their scope.
Journal ArticleDOI

Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021.

Rebecca K. Borchering, +60 more
TL;DR: In this paper, the authors used a multiple-model approach comprising six models to assess the potential course of COVID-19 in the United States across four scenarios with different vaccination coverage rates and effectiveness estimates and strength and implementation of nonpharmaceutical interventions (NPIs) (such as physical distancing and masking) over a 6-month period (April-September 2021) using data available through March 27, 2021 (4).
Journal ArticleDOI

A framework for evaluating epidemic forecasts

TL;DR: This paper presents an evaluation framework which allows for combining different features, error measures, and ranking schema to evaluate forecasts, and demonstrates the utility of the framework by evaluating six forecasting methods for predicting influenza in the United States.